triclabendazole has been researched along with Acute Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Carty, CI; Chandler, C; Hayes, CJ; Hoey, S; O'Brien, PJ; Piras, IM; Rhodes, V; Ryan, EG; Wolfe, A | 1 |
| Boggild, AK; Kain, D; Mukkala, AN | 1 |
| el-Toukhy, MA; Fouad, HN; Hishmat, M; Rawash, NA; Rehim, WM; Sharaf, IA | 1 |
| Bussalleu, A; Carrasco, C; Freedman, DO; Gotuzzo, E; Huerta-Mercado, J; Marcos, LA; Ramirez, C; Tagle, M; Terashima, A; Valdez, L; Vinetz, JM | 1 |
| Puente, GL | 1 |
| Allam, AF; Gabbour, SN; Sultan, MM | 1 |
| Hussein, DA; Tawfeek, GM | 1 |
1 review(s) available for triclabendazole and Acute Disease
| Article | Year |
|---|---|
Prolonged antibiotic use leading to Clostridium difficile colitis in an ill returned traveller with acute fascioliasis.
Topics: Acute Disease; Adult; Animals; Anti-Bacterial Agents; Antiplatyhelmintic Agents; Clostridium Infections; Colitis; Delayed Diagnosis; Diagnosis, Differential; Fasciola hepatica; Fascioliasis; Female; Humans; Liver Abscess; Magnetic Resonance Imaging; Travel; Triclabendazole | 2018 |
2 trial(s) available for triclabendazole and Acute Disease
| Article | Year |
|---|---|
Antioxidant capacity in Fasciola hepatica patients before and after treatment with triclabendazole alone or in combination with ascorbic acid (vitamin C) and tocofersolan (vitamin E).
Topics: Acute Disease; Adolescent; Adult; Anthelmintics; Antioxidants; Ascorbic Acid; Benzimidazoles; Chronic Disease; Drug Combinations; Erythrocytes; Fascioliasis; Female; Glutathione; Glutathione Peroxidase; Humans; Lipid Peroxides; Liver Function Tests; Male; Superoxide Dismutase; Triclabendazole; Vitamin E | 2003 |
IgM and IgG cystatin capture enzyme linked immunosorbent assays: a tool for serodiagnosis and assessment of cure of acute fascioliasis after triclabendazole (TCZ; Fasinex) therapy.
Topics: Acute Disease; Adult; Anthelmintics; Benzimidazoles; Cystatins; Enzyme-Linked Immunosorbent Assay; Fascioliasis; Female; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Triclabendazole | 2000 |
4 other study(ies) available for triclabendazole and Acute Disease
| Article | Year |
|---|---|
Acute fasciolosis in an alpaca: a case report.
Topics: Acute Disease; Amoxicillin; Animals; Anti-Bacterial Agents; Antiplatyhelmintic Agents; Camelids, New World; Colic; Fascioliasis; Ireland; Male; Treatment Outcome; Triclabendazole | 2021 |
Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis.
Topics: Acute Disease; Adult; Aged; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Benzimidazoles; Fasciola hepatica; Fascioliasis; Female; Humans; Liver; Male; Middle Aged; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triclabendazole | 2008 |
Acute and subacute Fasciolosis of alpacas (Lama pacos) and treatment with triclabendazole.
Topics: Acute Disease; Animals; Anthelmintics; Benzimidazoles; Camelids, New World; Fasciola; Fascioliasis; Female; Male; Peru; Triclabendazole | 1997 |
The pulmonary performance and airway reactivity in acute and chronic fascioliasis before and after triclabendazole treatment.
Topics: Acute Disease; Adolescent; Adult; Anthelmintics; Benzimidazoles; Bronchial Hyperreactivity; Child; Chronic Disease; Fascioliasis; Follow-Up Studies; Humans; Lung; Spirometry; Triclabendazole | 1997 |